Patentability of genetically engineered microorganisms.


A lawyer in the Office of the General Counsel of the American Medical Association discusses the case history and implications of the Supreme Court decision Diamond v. Chakrabarty. The court held that genetically engineered microorganisms were patentable subject matter under the Patent Act. Disclaiming broad application of its decision, the court limited its opinion to microbes engineered by Chakrabarty's method and deferred public policy issues to the legislative process, leaving the decision whether other life forms are patentable to the Patent Office and lower courts.

Cite this paper

@article{Cooper1983PatentabilityOG, title={Patentability of genetically engineered microorganisms.}, author={Arnie Cooper}, journal={JAMA}, year={1983}, volume={249 12}, pages={1553-4} }